1. Home
  2. CCSI vs STTK Comparison

CCSI vs STTK Comparison

Compare CCSI & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Consensus Cloud Solutions Inc.

CCSI

Consensus Cloud Solutions Inc.

N/A

Current Price

$43.00

Market Cap

684.3M

Sector

Technology

ML Signal

N/A

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

N/A

Current Price

$4.69

Market Cap

652.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CCSI
STTK
Founded
2021
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
684.3M
652.4M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
CCSI
STTK
Price
$43.00
$4.69
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
12
Target Price
★ $50.00
$15.40
AVG Volume (30 Days)
108.7K
★ 908.0K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 53.02
EPS
★ 3.88
N/A
Revenue
★ $349,696,000.00
$1,000,000.00
Revenue This Year
$3.40
N/A
Revenue Next Year
$4.22
$14.28
P/E Ratio
$11.11
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$20.20
$1.86
52 Week High
$45.68
$8.33

Technical Indicators

Market Signals
Indicator
CCSI
STTK
Relative Strength Index (RSI) 65.92 37.87
Support Level $33.37 $4.38
Resistance Level N/A $7.66
Average True Range (ATR) 2.06 0.40
MACD 0.67 -0.03
Stochastic Oscillator 75.53 18.47

Price Performance

Historical Comparison
CCSI
STTK

About CCSI Consensus Cloud Solutions Inc.

Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in the fax cloud business. The company's offerings include communication, data extraction, and digital signature solutions that enable users to securely access, exchange, and manage information across organizational and geographic boundaries. It serves multiple industry verticals, including healthcare, government, financial services, legal, and education. Geographically, the company operates in the United States, Canada, Ireland, and other countries. It derives the maximum revenue from the United States.

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Share on Social Networks: